Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.36 |
| ▸ | CDK9 | P50750 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.34 |
| ▸ | ESRRA | P11474 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4241180 | 1.00 | HDAC1 (0.41) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4244117 | 0.99 | HDAC1 (0.42) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4244118 | 0.99 | HDAC1 (0.42) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4241829 | 0.94 | CDK9 (0.40) | HDAC1ENPP2CDK9ESRRAMAPT | |
| SCHEMBL4241832 | 0.94 | CDK9 (0.40) | HDAC1ENPP2CDK9ESRRAMAPT | |
| SCHEMBL4242454 | 0.91 | HDAC1 (0.40) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4242457 | 0.91 | HDAC1 (0.40) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4249791 | 0.90 | HDAC1 (0.41) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4249794 | 0.90 | HDAC1 (0.41) | HDAC1MCHR1ENPP2CDK9ALDH1A1 | |
| SCHEMBL4244021 | 0.90 | ACVR1 (0.41) | HDAC1CDK9ALDH1A1MAPTSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090048252-A1 | THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION | 2009-02-19 | — | — | US | claimed |
| US-20090048252-A1 | THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION | 2009-02-19 | — | — | US | disclosed |
| US-20070249599-A1 | Novel Chemical Compounds | DUFFY KEVIN J | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249599-A1 | Novel Chemical Compounds | HIPK3, HIPK1, HIPK4 | HDAC1 2582/4885MCHR1 3365/4885ENPP2 1265/4885 |
| US-20090048252-A1 | THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS | PIK3CA, BTK, PI4KA | HDAC1 1247/4885MCHR1 4843/4885ENPP2 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.